Corrigendum to ‘Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014–2015’ [J Infect Chemother 23 (2017) 339–348]

Yoshio Takesue; Katsunori Yanagihara; Koji Okabayashi; Yasushi Harihara; Yoshiyasu Ambo; Koshi Matsui; Toru Mizuguchi; Satoshi Iwata; Kohji Okamoto; Mitsuo Kaku; Hiroki Ohge; Shoji Kubo; Ryohei Kawabata; Masafumi Konosu; Kazuhisa Uchiyama; Minàko Kobayashi; Hideaki Hanaki; Junko Sato; Kazuo Hase; Junzo Shimizu; Keiichiro Ishibashi; Shiko Seki; Katsunori Suzuki; Yuko Kitagawa; Takuo Hara; Masaaki Oka; Yoichi Matsuo; Akira Watanabe; Yoshinobu Sumiyama; Hiroshi Kiyota; Hiroshige Mikamo; Shinya Kusachi; Shinji Akagi; Toshiro Wakatsuki; Akihisa Matsuda

doi:10.1016/j.jiac.2017.11.009

Corrigendum to ‘Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014–2015’ [J Infect Chemother 23 (2017) 339–348]

Yoshio Takesue(Hyogo Medical University), Katsunori Yanagihara(Nagasaki University), Koji Okabayashi(Keio University), Yasushi Harihara(The University of Tokyo), Yoshiyasu Ambo(Hokkaido University of Science), Koshi Matsui(University of Toyama), Toru Mizuguchi(Sapporo Medical University), Satoshi Iwata(Tokyo Medical University), Kohji Okamoto(Kitakyushu City Hospital Organization), Mitsuo Kaku(St. Marianna University School of Medicine), Hiroki Ohge(Hiroshima University Hospital), Shoji Kubo(Osaka Metropolitan University), Ryohei Kawabata(Osaka International Cancer Institute), Masafumi Konosu(Iwate Medical University), Kazuhisa Uchiyama(Daiichi-Sankyo (Japan)), Minàko Kobayashi(Mie University), Hideaki Hanaki(Kitasato University), Junko Sato(Japan Society of Chemotherapy), Kazuo Hase(Self-Defense Forces Central Hospital), Junzo Shimizu(Osaka Rosai Hospital), Keiichiro Ishibashi(Saitama Medical University), Shiko Seki(Tokyo Medical Center), Katsunori Suzuki(University of Occupational and Environmental Health Japan), Yuko Kitagawa(Keio University), Takuo Hara(Kouseiren Takaoka Hospital), Masaaki Oka(Yamaguchi University), Yoichi Matsuo(Nagoya City University), Akira Watanabe(Shizuoka Cancer Center), Yoshinobu Sumiyama(Toho University), Hiroshi Kiyota(Japan Society of Chemotherapy), Hiroshige Mikamo(Aichi Medical University Hospital), Shinya Kusachi(Toho University), Shinji Akagi(Mazda Motor Corporation (Japan)), Toshiro Wakatsuki(Tottori University), Akihisa Matsuda(Nippon Medical School)

Journal of Infection and Chemotherapy

November 30, 2017

10.1016/j.jiac.2017.11.009

Cited by 1

|Hepatology Research|2019|539

Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer

|British journal of surgery|2018|401

Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer

|Annals of Surgery|2007|315

Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer

|Annals of Surgery|2019|298

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

|Hepatology Research|2023|281

Corrigendum to ‘Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014–2015’ [J Infect Chemother 23 (2017) 339–348]

Related Papers